View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 21, 2022
1 min read
Save

Healthy lifestyle behaviors may lower risk for dementia in type 2 diabetes

Healthy lifestyle behaviors may lower risk for dementia in type 2 diabetes

Living a healthier lifestyle can lower the risk for dementia for adults with type 2 diabetes, according to a speaker at the European Association for the Study of Diabetes annual meeting.

SPONSORED CONTENT
September 20, 2022
2 min read
Save

Balanced diet associated with better cognitive function

Balanced diet associated with better cognitive function

Maintaining a balanced energy intake through diet was associated with significantly better cognitive function compared with uneven intake patterns, researchers reported in Life Metabolism.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
September 20, 2022
3 min watch
Save

VIDEO: Resiliency 'isn't the answer' to physician burnout

VIDEO: Resiliency 'isn't the answer' to physician burnout

CHICAGO — When struggling with burnout, many health care providers are expected to simply be more resilient, but this does not address the system creating these problems, according to two speakers.

SPONSORED CONTENT
September 20, 2022
1 min read
Save

Phase 2 trial of therapeutic for patients with early AD yields positive results

Phase 2 trial of therapeutic for patients with early AD yields positive results

Alzheon Inc. reported statistically significant and clinically relevant results in patients with Alzheimer’s disease following 12 months of treatment with the oral investigational therapeutic ALZ-801 in its phase 2 trial.

SPONSORED CONTENT
September 20, 2022
1 min read
Save

Patients with AS receiving TNF inhibitors have lower rates of Alzheimer’s disease

Patients with AS receiving TNF inhibitors have lower rates of Alzheimer’s disease

Although ankylosing spondylitis correlates with higher rates of Alzheimer’s disease, patients who receive TNF inhibitors are less likely to develop the neurologic disorder, according to data published in Pharmacological Research.

SPONSORED CONTENT
September 19, 2022
1 min read
Save

Metabolites associated with sugary diet linked to cognitive function in older adults

Metabolites associated with sugary diet linked to cognitive function in older adults

Six metabolites — four related to sugar — were consistently associated with lower global cognitive function, researchers reported in Alzheimer’s & Dementia.

SPONSORED CONTENT
September 19, 2022
2 min read
Save

Monkeypox linked to encephalitis, confusion, seizures

Monkeypox linked to encephalitis, confusion, seizures

Preliminary evidence suggests there is an association between monkeypox and neuropsychiatric complications, including encephalitis, confusion and seizures, a study published in EClinicalMedicine found.

SPONSORED CONTENT
September 19, 2022
1 min read
Save

Phase 2a cognition, dementia treatment trial underway

Phase 2a cognition, dementia treatment trial underway

CuraSen Therapeutics Inc. announced it has begun dosing patients in a phase 2a clinical trial with CST-2032, an oral therapeutic for treatment of mild cognitive impairment or mild dementia due to either Parkinson’s or Alzheimer’s disease.

SPONSORED CONTENT
September 19, 2022
1 min read
Save

NIH awards Cedars-Sinai $8M for AI-based Alzheimer's research

NIH awards Cedars-Sinai $8M for AI-based Alzheimer's research

Cedars-Sinai’s department of computational biomedicine has been awarded an $8 million NIH grant to use artificial intelligence methods to identify genetic predictors of Alzheimer's disease.

SPONSORED CONTENT
September 19, 2022
2 min read
Save

FDA grants accelerated approval for gene therapy to treat cerebral adrenoleukodystrophy

FDA grants accelerated approval for gene therapy to treat cerebral adrenoleukodystrophy

The FDA granted accelerated approval to bluebird bio Inc for elivaldogene autotemcel, its gene therapy that aims to slow progression of neurologic dysfunction in boys aged 4 to 17 with early, active cerebral adrenoleukodystrophy, or CALD.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails